The quality of life of patients with coronary heart disease with diffuse coronary lesion at different times after CABG, supplemented by the Yurleon procedure

In the recent decades, coronary heart disease (CHD) has consistently occupied a leading place in the structure of morbidity and mortality in cardiovascular diseases. One of the most effective methods of treating this pathology is direct myocardial revascularization - coronary artery bypass surgery (CABG), which allows not only to increase the survival rate of patients, but also to improve their quality of life. However, in patients with diffuse lesions of the coronary arteries, CABG and PCI are not effective. It allows to improve the results of extracardial myocardial revascularization, which is based on the principle of stimulating angiogenesis in order to create anastomoses between the coronary bed and the arterial systems of various mediastinal tissues surrounding the heart. This is achieved by a specially developed surgical and biotechnological technology called YurLeon. Aim. Comparison of the quality of life of patients at different times after isolated coronary bypass surgery and supplemented with the YurLeon procedure. Materials and methods. The study included 1070 patients with a diagnosis of CHD, angina pectoris III, IV FC, 645 men (60.28%) and 425 (39.72%) women, aged from 50 to 75 years (65.79±10.45) were included. General clinical data, quality of life indicators, gated-SPECT, echocardiography, computer tomography results were evaluated in the immediate and long-term postoperative period. Results. At the intraoperative stage and in the early postoperative period, there were no significant differences in the indicators of complications between the two groups (p>0.05). There were statistically significant differences after 12 months, in the LV ejection fraction: 52.55±5.98% (CABG) and 57.0±5.78% (CABG+YurLeon) (p function show_eabstract() { $('#eabstract1').hide(); $('#eabstract2').show(); $('#eabstract_expand').hide(); }